Table 2 Summary of Case study

1st Author Sample size Mean age or ranges(years)(Sex, M/F) Chief Complaint Treatment Treatment duration Scale
Lee MS 1 33(0/1) vertigo, tinnitus, aural fullness A-Tx, H-med, W-med 7 w GAS
Lee SY 1 34(1/0) vertigo, nausea, vomiting, tinnitus, hearing loss A-Tx, M-Tx, H-med 32 d change of symptoms
Lee SE 2 63(1/1) M: vertigo, Lt. tinnitus, Lt. ear hearing lossF: vertigo, Rt. tinnitus, Rt. ear fullness, Rt. ear hearing loss(transient) A-Tx, H-med 2 m FV, HT, FL, vertigo score, change of symptoms
Lee KJ 2 39(2/0) 55 y: vertigo, vomiting, Lt. tinnitus, hearing loss. / 23 y: vertigo, vomiting, Rt. tinnitus, hearing loss(mild) A-Tx, H-med, N-Tx, Infra-red in progress/40 d HT, change of symptoms
Park JY 1 37(0/1) Rt. tinnitus, Rt. ear hearing loss, vertigo A-Tx, M-Tx, N-Tx, H-med 49 d HT, change of symptoms
Lee HH 1 34(1/0) vertigo, headache A-Tx, H-med 27 d change of symptoms
Oh KC 1 64(0/1) vertigo, hearing loss, tinnitus, nausea, secretion of inner ear A-Tx, H-med 25 d VAS
Zhang KL 30 38.19±4.75 (12/18) vertigo, tinnitus, aural fullness, hearing loss, nausea, vomiting, nystagmus auricular A-TxH-med 10~30 d cure rate index
Bai RH 30 38-62 (10/20) n.r. A-Tx, M-Tx n.r. change of symptoms, recurrence or not
Feng JP 26 26-66 (12/14) n.r. Scalp A-Tx, A-Tx 2~7 d change of symptoms, recurrence or not
Liu SQ 86 48 (54/32) vertigo, nausea, vomiting, aural fullness, tinnitus, hearing loss, nystagmus Scalp A-Tx, H-med n.r. change of symptoms, HT
Ling N 12 21-63 (5/7) n.r. Miniscalpel A-Tx 20 d change of symptoms, recurrence or not
F: female, M: male, A-Tx: acupuncture treatment, H-med: herbal medicine, W-med: western medicine, M-Tx: moxibustion treatment, N-Tx: negative treatment, y: year, w: week, m: month, d: day, GAS: Global Assessment Scale, FV: Frequency of Vertigo, HT: Hearing Threshold, FL: Function Level, VAS: Visual Analogue Scale, n.r.: not reported